Value Set Information
Value Set Code PHVS_VISVaccines_IIS Download Value Set Download Value SetDownload Value SetDownload Value Set
Value Set Name VIS Vaccines (IIS)
Value Set OID 2.16.840.1.114222.4.11.6040
Value Set Description This table lists the vaccines which require that a Vaccine Information Statement (VIS) be shared with a patient/parent. The VIS document type, edition date and presentation date are reported in a set of OBX. Subscribe
Version History

        Concept Code Concept Name Preferred Concept Name Code System Value Set  
143 Adenovirus types 4 and 7 Adenovirus types 4 and 7 Vaccines administered (CVX) VIS Vaccines (IIS) Details
24 anthrax anthrax Vaccines administered (CVX) VIS Vaccines (IIS) Details
174 cholera, live attenuated cholera, live attenuated Vaccines administered (CVX) VIS Vaccines (IIS) Details
211 COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, Subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL per dose Vaccines administered (CVX) VIS Vaccines (IIS) Details
212 COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL Vaccines administered (CVX) VIS Vaccines (IIS) Details
210 COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL Vaccines administered (CVX) VIS Vaccines (IIS) Details
218 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation Vaccines administered (CVX) VIS Vaccines (IIS) Details
207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose Vaccines administered (CVX) VIS Vaccines (IIS) Details
219 COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation Vaccines administered (CVX) VIS Vaccines (IIS) Details
208 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose Vaccines administered (CVX) VIS Vaccines (IIS) Details
217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation Vaccines administered (CVX) VIS Vaccines (IIS) Details
28 DT (pediatric) diphtheria and tetanus toxoids, adsorbed for pediatric use Vaccines administered (CVX) VIS Vaccines (IIS) Details
20 DTaP DTaP Vaccines administered (CVX) VIS Vaccines (IIS) Details
106 DTaP, 5 pertussis antigens DTaP, 5 pertussis antigens Vaccines administered (CVX) VIS Vaccines (IIS) Details
146 DTaP,IPV,Hib,HepB DTaP,IPV,Hib,HepB Vaccines administered (CVX) VIS Vaccines (IIS) Details